Stocks and Investing
Stocks and Investing
Tue, March 21, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
William Pickering Initiated (ALLO) at Hold and Held Target at $6 on, Mar 21st, 2023
William Pickering of Bernstein, Initiated "Allogene Therapeutics, Inc." (ALLO) at Hold and Held Target at $6 on, Mar 21st, 2023.
William has made no other calls on ALLO in the last 4 months.
There are 9 other peers that have a rating on ALLO. Out of the 9 peers that are also analyzing ALLO, 1 agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Chaiken of "JMP Securities" Maintained at Hold with Decreased Target to $19 on, Thursday, March 2nd, 2023
These are the ratings of the 8 analyists that currently disagree with William
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $31 on, Thursday, March 2nd, 2023
- Tony Butler of "EF Hutton" Reiterated at Strong Buy and Held Target at $15 on, Wednesday, March 1st, 2023
- Luca Issi of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Wednesday, March 1st, 2023
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $28 on, Wednesday, March 1st, 2023
- Brian Cheng of "JP Morgan" Upgraded from Hold to Buy and Decreased Target to $11 on, Tuesday, January 24th, 2023
- Jack Allen of "Baird" Upgraded from Hold to Buy and Held Target at $12 on, Friday, January 6th, 2023
- Jason Gerberry of "B of A Securities" Downgraded from Strong Buy to Sell and Held Target at $9 on, Monday, December 12th, 2022
- Debjit Chattopadhyay of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $29 on, Monday, November 21st, 2022
Contributing Sources